Inovio Pharmaceuticals
INO
INO
125 hedge funds and large institutions have $142M invested in Inovio Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.65% less ownership
Funds ownership: 2.95% → 2.3% (-0.65%)
28% less capital invested
Capital invested by funds: $196M → $142M (-$54.5M)
Holders
125
Holding in Top 10
–
Calls
$3.22M
Puts
$2.99M
Top Buyers
| 1 | +$2.4M | |
| 2 | +$1.65M | |
| 3 | +$1.38M | |
| 4 |
Citigroup
New York
|
+$689K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$413K |
Top Sellers
| 1 | -$7.43M | |
| 2 | -$3.01M | |
| 3 | -$2.24M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.51M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.33M |